Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 1355 | 4,662,223,648 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| ENLIVEN THERAPEUTICS INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
| VOR BIOPHARMA INC | COM | 1652 | $366,075 | 162,700 | 0.00 | 0.00 | 62,500 | 62.38 | 12-31-2023 |
| G1 THERAPEUTICS INC | COM | 1653 | $366,000 | 120,000 | 0.00 | 0.00 | 5,000 | 4.35 | 12-31-2023 |
| CO-DIAGNOSTICS INC | COM | 1654 | $362,957 | 272,900 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
